CAM Use Among Migraine/Headache Sufferers Investigated

By August 02, 2017

The use of complementary and alternative medicine (CAM) specifically for the treatment of migraine and headache is "relatively low" in the U.S.

Teva Launches Generic Relpax

By August 02, 2017

Its agonist effects at the 5-HT1B/1D receptors on intracranial blood vessels and sensory nerves of the trigeminal system result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release.

FDA: Migraine Patch May Cause Serious Burns, Scarring

By June 02, 2016

Since September 2015, there have been numerous reports of burns or scars where the patch was applied.